Innovative medicine ETF (159992) has inflows for 6 consecutive days, and the increase in Midi and Yaoming Kanto

On September 26, the innovative pharmaceutical sector was active.My martial arts, East China Pharmaceuticals have risen, Meidi, Yaoming Kangde, Jiuzhou Pharmaceutical, and Tiger Pharmaceuticals have risen, driving innovative drug ETF (159992) shock rebound, and the current turnover exceeds 74 million yuan.The market continues to pay attention to the performance of the innovative pharmaceutical sector, and the innovative drug ETF (159992) has a net inflow of funds for 6 consecutive trading days.

Guosheng Securities said that my country's innovative drug market has gradually entered the moment of "pan -innovation" to "selected high -quality innovation".Monkey -resistant popular targets will continue to be fierce in the future of homogeneous competition, and homogeneous products will gradually lose its competitiveness. New technologies, scarce technology platforms, differentiated treatment areas, and innovative administration methods may be brought to enterprises.In a better competitive pattern, companies with technical precipitation are expected to stand out.

- END -